![Frank Mathias](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frank Mathias
Vorstandsvorsitzender bei
OXFORD BIOMEDICA PLC
Vermögen: 157 840 $ am 30.09.2026
Profil
Dr. Frank Mathias is a Chairman at ArcticZymes Technologies ASA, a Chief Executive Officer & Director at Oxford Biomedica Plc, a Chairman at Vfa Bio, a Chairman-Supervisory Board at August Faller GmbH & Co. KG and a Chief Executive Officer at OXB US, Inc. He is on the Board of Directors at Oxford Biomedica Plc, Rentschler Biopharma SE, Seqens SAS, leon-nanodrugs GmbH, LEUKOCARE AG, Mediatum GmbH and Rentschler Biotechnologie Beteiligungs GmbH.
Dr. Mathias was previously employed as an Independent Member-Supervisory Board by MediGene AG, a Member-Executive Board by MediGene AG, a Chief Executive Officer by AMGEN GmbH, a Chief Executive Officer by Dr. Rentschler Holding GmbH & Co. KG, a Manager-International Product by Hoechst AG, and a General Manager by Servier Deutschland GmbH.
He also served on the board at Catherex, Inc.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
OXFORD BIOMEDICA PLC 0,02 % | 31.12.2025 | 20 000 ( 0,02 % ) | 138 690 $ | 30.09.2026 |
| 31.12.2025 | 9 000 ( 0,02 % ) | 19 150 $ | 30.09.2026 |
Aktive Positionen von Frank Mathias
| Unternehmen | Position | Beginn |
|---|---|---|
| OXFORD BIOMEDICA PLC | Vorstandsvorsitzender | 27.03.2023 |
| ARCTICZYMES TECHNOLOGIES ASA | Vorsitzender | 26.06.2024 |
August Faller GmbH & Co. KG
 August Faller GmbH & Co. KG Containers/PackagingProcess Industries Manufactures goods made from paper, cardboard and corrugated board products | Vorsitzender | - |
Vfa Bio | Vorsitzender | - |
Rentschler Biotechnologie Beteiligungs GmbH
 Rentschler Biotechnologie Beteiligungs GmbH Financial ConglomeratesFinance Provides investment services | Direktor/Vorstandsmitglied | - |
LEUKOCARE AG
 LEUKOCARE AG Medical/Nursing ServicesHealth Services Develops protein stabilization and protection solutions | Direktor/Vorstandsmitglied | - |
leon-nanodrugs GmbH
 leon-nanodrugs GmbH Information Technology ServicesTechnology Services Provides technology solutions for nanoparticle manufacturing | Direktor/Vorstandsmitglied | - |
Mediatum GmbH | Direktor/Vorstandsmitglied | - |
Rentschler Biopharma SE
 Rentschler Biopharma SE Pharmaceuticals: MajorHealth Technology Develops and produces pharmaceutical products | Direktor/Vorstandsmitglied | 31.03.2023 |
Ehemalige bekannte Positionen von Frank Mathias
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ | ░░░░░░░░░░ | - |
| ░░░ ░░░░░░░░░░ ░░░░░░░ ░░░░ ░░░░░ ░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Frank Mathias
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
73
Beziehungen ersten Grades
17
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 17 |
|---|---|
Hoechst AG
 Hoechst AG Chemicals: Major DiversifiedProcess Industries Produces specialty chemicals and pharmaceutical products | Process Industries |
MediGene AG
 MediGene AG BiotechnologyHealth Technology Engages in the clinical research and development of novel drugs against cancer & autoimmune diseases with focus on personalized immunotherapies | Health Technology |
Oxford Biomedica Plc
 Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
ArcticZymes Technologies ASA
 ArcticZymes Technologies ASA Medical SpecialtiesHealth Technology Develops and manufactures immune modulating compounds | Health Technology |
AMGEN GmbH
 AMGEN GmbH BiotechnologyHealth Technology Develops, manufactures, and markets therapeutics based on cellular biology | Health Technology |
Rentschler Biopharma SE
Rentschler Biopharma SE Pharmaceuticals: MajorHealth Technology Develops and produces pharmaceutical products | Health Technology |
Dr. Rentschler Holding GmbH & Co. KG
 Dr. Rentschler Holding GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services Operates as a holding company with interests in pharmaceutical research and production | Commercial Services |
Université Pierre et Marie Curie
 Université Pierre et Marie Curie Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seqens SAS
 Seqens SAS Chemicals: SpecialtyProcess Industries Manufactures vegetal active ingredients for cosmetics | Process Industries |
August Faller GmbH & Co. KG
August Faller GmbH & Co. KG Containers/PackagingProcess Industries Manufactures goods made from paper, cardboard and corrugated board products | Process Industries |
LEUKOCARE AG
LEUKOCARE AG Medical/Nursing ServicesHealth Services Develops protein stabilization and protection solutions | Health Services |
Servier Deutschland GmbH
 Servier Deutschland GmbH Pharmaceuticals: MajorHealth Technology Engages in research, development and distribution of pharmaceutical products | Health Technology |
Catherex, Inc.
 Catherex, Inc. Miscellaneous Commercial ServicesCommercial Services Provides medical research services | Commercial Services |
Mediatum GmbH | |
leon-nanodrugs GmbH
leon-nanodrugs GmbH Information Technology ServicesTechnology Services Provides technology solutions for nanoparticle manufacturing | Technology Services |
Rentschler Biotechnologie Beteiligungs GmbH
Rentschler Biotechnologie Beteiligungs GmbH Financial ConglomeratesFinance Provides investment services | Finance |
Vfa Bio |
